Obstetric Cholestasis - GT 43 +TOG: Intrahepatic Cholestasis of Pregnancy Flashcards

1
Q

What % of pregnancies are affected by obstetric cholestasis?

A
  1. 7%

1. 2-1.5% of women of Indian/Pakistani descent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the perinatal risks of obstetric cholestasis?

A
  • Spontaneous/iatrogenic preterm birth
  • Increased risk CS
    fetal distress in labour
  • Fetal Death - likely small; risk above background not determined
  • Increase risk meconium passage proportional to bile acids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What % of women with obstetric cholestasis suffer with pruritis?

A

23%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the differential diagnoses of pruritis in pregnancy?

A

Eczema
Atopic eruption of pregnancy
Dermatographia artefacta (excoriations)
If rash - consider PEP/pemphigoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the risk factors for obstetric cholestasis?

A
Personal/family history
Multiple pregnancy
Hepatitis C
Gallstones
IVF
older women
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What should be ruled out before diagnosing obstetric cholestasis?

A
  • Viral screen - Hep A, B, C, EBV, CMV
  • Liver autoimmune screen - Chronic active hepatitis and
    PBC (i.e. anti-smooth muscle, antimitochondrial
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What should be considered in atypical/early cases of obstetric cholestasis?

A

PET

Acute fatty liver of pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the recommended monitoring for women diagnosed with obstetric cholestasis?

A
  • LFTs weekly until delivery (consider coag screen if rapid elevation as atypical)
  • Defer LFTs until 10 days postnatal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the treatment for obstetric cholestasis?

A
  • Topical emolients
  • Antihistamines for sedation
  • Ursodeoxycholic acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When should Vitamin K be used in treatment of obstetric cholestasis?

A

If PT prolonged needs 5-10mg Vitamin K daily, or woman has steatorrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the recurrence rate of obstetric cholestasis?

A

45-90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the contraceptive advice for women who have had obstetric cholestasis?

A

Best to avoid oestrogenic compounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What environemntal factors are thought to influence risk of ICP (intrahepatic cholestasis of Pregnancy)

A

dietary selenium & vitamin D, seasonal cariation- more cases diagnosed in winter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

in what percentage of women does obs chole present after 30/40?

A

80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what percentage of women suffer with jaundice associated with obs chole?

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the most sensitive and specific marker for diagnosing and monitoring obs chole?

A

bile acids

17
Q

if a woman who is 30/40 pregnant presents with itching suggestive of obstetric cholestasis, but bile acids and LFT’s are normal and itching continues, what suggestion has been made about how she should be managed?

A

if >24/40- weekly bile acids & LFTs until delivery

if <24/40- fortnightly bile acids &LFT’s

18
Q

if woman with obs chole presents with steatorrhoea, what blood test should be considered and why

A

coag screen- risk of malabsorption of fats and fat-soluble vitamins.

19
Q

what level of bile acid is associated with particular concern for adverse perinatal outcomes?

A

bile acid >40

20
Q

how does UDCA affect bile acids?

A

decreases level of bile acids in maternal and umbilical cord serum. Also causes qualitative changes in serum bile acid pool- consequent reduction of hydrophobicity of the pool

21
Q

what protective effects does UDCA have?

A

reduced risks preterm labour, reduced fetal distress during labour, reduced NNU admission

22
Q

what is a possible second line treatment for obstetric cholestasis

A

rifampicin- reduced pruritis and enhances bile acid secretion in primary biliary cirrhosis

23
Q

in what percentage of women treated with dual therapy- UDCA and rifampicin for obs chole, did the bile acid level reduce?

A

50% of women treated had reduced bile acid levels

24
Q

what are the future health risks for women with obstetric cholestasis?

A

increased incidence hepato-biliary disease (hepatitis, chronic hepatitis, hepatic fibrosis) in women with ICP

25
what other diseases have been associated with women who have history of ICP
increased risk of liver cancer, cardiovascular disease, maternal diabetes children of women with ICP are also at risk of metabolic disease later in life